Ochre Bio Company
![](/files/companies/Ochre%20Bio.png)
Ochre Bio is developing therapies for the biggest liver health challenges.
Investors
Connections from
Headquarters:
Oxford, Oxfordshire, United Kingdom
Total Funding:
39750000.0
Founded Date:
2019-09-01
Employee Number:
11-50
Last Funding Type:
Series A
Investors Number:
19.0
Last Funding Date:
2022-10-10
Technology:
Biopharma, Biotechnology, Health Care, Therapeutics
Funding Status:
Early Stage Venture
Estimated Revenue:
Less than $1M
Industry:
Early Drug Development